This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
193 posters, 19 videos, 10 audios, 3 topics, 28 sessions, 709 authors, 279 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
15 - 17 April, 2026 | Valencia, Spain

155
Šárka Havelková, Barbora Šimková, Jana Pavlíčková, Tomáš Vymazal
OutsidetheProtocol: Real-World Challenges in Paediatric Vascular Access
Background: Motol and Homolka University Hospital, Prague (Czech Republic) is a national tertiary (super-specialised) referral centre. Our paediatric vascular access team was established in 2018 within the Department of Anaesthesiology and Intensive Care Medicine. We deliver>12,000 paediatric anaesthetics annually and place ~900 central venous catheters per year (16% medium-/long-term), following contemporary recommendations (e.g., WoCoVa-endorsed pathways such as RACEVA/RAFAEMA/RAPEVA).
Methods: We report three representative “greyzone” cases in which guideline-based paediatric vascular access required adaptation due to time-critical conditions or anatomy-/physiology-related limitations.
Results: Deviations included: (1) exceeding the recommended catheter-to-vein ratio (>1/3) to achieve necessary access; (2) catheter insertion via the brachiocephalic vein despite a mediastinal mass because no safer route was available; and (3) femoral access with temporary non-ideal tip position due to post–liver transplantation inferior vena cava changes limiting safe advancement. Early complications and clinical rationale are described.
Conclusion: “Greyzone” patients—typically critically ill children with complex histories and limited access options—will continue to require individualised approaches when standard algorithms are not feasible or safe. Structured multidisciplinary decision-making, explicit risk–benefit documentation, and a predefined follow-up plan (function, insertion site and tip surveillance, and early detection of thrombosis/infection) are essential to minimise risk and enable timely intervention.